Popular Articles

Disease Markers That Will Aid Arthritis Research
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central"s open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs.
diet pills
Developing Gene Therapy To Fight Blindness
An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease. The therapy has been shown to restore lost vision in animal models of retinitis pigmentosa (RP). Their work is being funded in part by a $1.5 million grant from the Prince Salman Center for Disability Research in Saudi Arabia, where the recessive gene mutation that leads to the eye disease RP has been found in children from several families.
News of the day
Studies Reveal Hepatitis C Virus Carriers Experience Substantial Increase In Mortality
Hepatitis C virus (HCV) is a blood-borne disease that causes inflammation of the liver and to which there is currently no vaccine available. The World Health Organization (WHO) estimates that 3% of the world"s population, approximately 170 million people, are infected with HCV and it is a leading cause of liver cirrhosis, end stage liver disease, hepatocellular carcinoma (HCC) and liver transplantation.
Nutrition

Breakthrough Swine Flu Test

A leading Melbourne scientist has unveiled a test able to detect Swine Flu, or any other virus, within hours. The test, known as the RETCIF™ test, is a simple test carried out on a patient sample (such as a nasal swab). Any viruses present in the sample are grown rapidly in a patented culture before being examined under a fluorescent microscope. Other viral diagnostic tests do not work as accurately in a rapid manner. The company behind the test is Pallane Medical Pty Limited (Pallane). The Chief Scientific Officer of Pallane say the RETCIF™ test is "almost 100 per cent accurate" and is currently the most effective way of testing for live viruses, including the Swine Flu virus. The test, developed by leading Melbourne virologist, Dr Robert Alexander, has been used extensively at the Royal Children"s Hospital. It has been used to diagnose viruses in patients but, to date, has never been widely available to the general community or on a commercial basis. Pallane CEO Peter King said that the RETCIF™ test had the potential to revolutionise viral testing around the world, and not just in relation to Swine Flu. "Within one to three hours we can actually tell if someone has a virus - and to tell you what type of virus or multiple viruses a patient has takes approximately 24 hours," he said. The RETCIF™ test may be used at airports in the event of any viral pandemic (including a Swine Flu pandemic), so at risk travellers, who are yet to show symptoms, could be tested and released quickly rather than quarantined for days. If the test shows a person has contracted a virus or viruses, but is yet to show symptoms, anti-viral medication could be immediately prescribed to mitigate the possibility of serious illness. The RETCIF™ test is expected to be commercially available internationally within 24 months. Pallane Medical Pty Limited


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):